Sanchun Wang1, Yu Cai1, Qingjie Feng1, Jing Gao2, Bo Teng3. 1. Department of Otorhinolaryngology Head and Neck Surgery, The Second Hospital of Jilin University, Changchun, China. 2. State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China. 3. Department of Otorhinolaryngology Head and Neck Surgery, The Second Hospital of Jilin University, Changchun, China. tengbo@jlu.edu.cn.
Abstract
BACKGROUND: Ginsenosides have been reported to possess a variety of biological activities. Synthesized from the ginsenoside protopanaxadiol (PPD), the octanone pseudoginsengenin DQ (PDQ) may have robust pharmacological effects as a secondary ginsenoside. Nevertheless, its antitumour activity and molecular mechanism against hypopharyngeal cancer cells remain unclear. METHODS: Cell Counting Kit8 assays, cell cycle assays and cell apoptosis assays were conducted to assess FaDu cell proliferation, cell phase and apoptosis. The interactions between PDQ and HIF-1α were investigated by a molecular docking study. The expression of HIF-1α, GLUT1, and apoptosis-related proteins was detected by Western blotting, direct stochastic optical reconstruction microscopy (dSTORM) and qRT-PCR. A glucose uptake assay was used to assess the glucose uptake capacity of FaDu cells. RESULTS: PDQ suppressed proliferation, reduced glucose uptake, and induced cell cycle arrest and apoptosis in FaDu cells. A molecular docking study demonstrated that PDQ could interact with the active site of HIF-1α. PDQ decreased the expression and mRNA levels of HIF-1α and its downstream factor GLUT1. Moreover, the dSTORM results showed that PDQ reduced GLUT1 expression on the cell membrane and inhibited GLUT1 clustering. CONCLUSION: Our work showed that the antitumour effect of PDQ was related to the downregulation of the HIF-1α-GLUT1 pathway, suggesting that PDQ could be a potential therapeutic agent for hypopharyngeal cancer treatment.
BACKGROUND:Ginsenosides have been reported to possess a variety of biological activities. Synthesized from the ginsenoside protopanaxadiol (PPD), the octanone pseudoginsengenin DQ (PDQ) may have robust pharmacological effects as a secondary ginsenoside. Nevertheless, its antitumour activity and molecular mechanism against hypopharyngeal cancer cells remain unclear. METHODS: Cell Counting Kit8 assays, cell cycle assays and cell apoptosis assays were conducted to assess FaDu cell proliferation, cell phase and apoptosis. The interactions between PDQ and HIF-1α were investigated by a molecular docking study. The expression of HIF-1α, GLUT1, and apoptosis-related proteins was detected by Western blotting, direct stochastic optical reconstruction microscopy (dSTORM) and qRT-PCR. A glucose uptake assay was used to assess the glucose uptake capacity of FaDu cells. RESULTS:PDQ suppressed proliferation, reduced glucose uptake, and induced cell cycle arrest and apoptosis in FaDu cells. A molecular docking study demonstrated that PDQ could interact with the active site of HIF-1α. PDQ decreased the expression and mRNA levels of HIF-1α and its downstream factor GLUT1. Moreover, the dSTORM results showed that PDQ reduced GLUT1 expression on the cell membrane and inhibited GLUT1 clustering. CONCLUSION: Our work showed that the antitumour effect of PDQ was related to the downregulation of the HIF-1α-GLUT1 pathway, suggesting that PDQ could be a potential therapeutic agent for hypopharyngeal cancer treatment.
Authors: Phoebe Kuo; Julie A Sosa; Barbara A Burtness; Zain A Husain; Saral Mehra; Sanziana A Roman; Wendell G Yarbrough; Benjamin L Judson Journal: Cancer Date: 2016-03-28 Impact factor: 6.860
Authors: J Robert Newman; Timothy M Connolly; Elisa A Illing; Meredith L Kilgore; Julie L Locher; William R Carroll Journal: Laryngoscope Date: 2014-09-15 Impact factor: 3.325
Authors: Marek Samec; Alena Liskova; Lenka Koklesova; Sandra Mersakova; Jan Strnadel; Karol Kajo; Martin Pec; Kevin Zhai; Karel Smejkal; Sepideh Mirzaei; Kiavash Hushmandi; Milad Ashrafizadeh; Luciano Saso; Aranka Brockmueller; Mehdi Shakibaei; Dietrich Büsselberg; Peter Kubatka Journal: Cancers (Basel) Date: 2021-01-03 Impact factor: 6.639
Authors: Patrick Ying Kit Yue; Nai Ki Mak; Yuen Kit Cheng; Kar Wah Leung; Tzi Bun Ng; David Tai Ping Fan; Hin Wing Yeung; Ricky Ngok Shun Wong Journal: Chin Med Date: 2007-05-15 Impact factor: 5.455